EXAGEN INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Exagen Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2024.
  • Exagen Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$100K, a 61.3% decline year-over-year.
  • Exagen Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$10.6M, a 2074% decline from 2022.
  • Exagen Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$489K, a 101% decline from 2021.
  • Exagen Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $64.7M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$100K -$38K -61.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 -$62K -$32K -107% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 -$30K -$65.1M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $65.1M +$65.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 -$51K -$3.53M -101% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $3.48M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.